{"id":454,"date":"2026-09-11T10:47:45","date_gmt":"2026-09-11T10:47:45","guid":{"rendered":"https:\/\/worldcannabisconferences.com\/nueva\/wp\/ponentes\/sagnik-bhattacharyya-en\/"},"modified":"2026-09-11T10:47:45","modified_gmt":"2026-09-11T10:47:45","slug":"sagnik-bhattacharyya-en","status":"publish","type":"wcc_ponente","link":"https:\/\/worldcannabisconferences.com\/conferencias\/en\/speakers\/sagnik-bhattacharyya\/","title":{"rendered":"Sagnik Bhattacharyya"},"content":{"rendered":"<p>Dr. Sagnik Bhattacharyya is a Senior Clinical Lecturer and Consultant Psychiatrist at the Institute of Psychiatry, Psychology &#038; Neuroscience at King\u2019s College London and the associated Maudsley hospital, UK. Following his initial medical and psychiatric training in India, he went to the UK, where he had further training in psychiatry at the Maudsley hospital and the Institute of Psychiatry in London and subsequently obtained a PhD at King\u2019s College London. He has not left King\u2019s ever since and has been employing experimental medicine approaches to understand the neural and genetic basis of the effects of cannabis in man. He has been the recipient of a number of prestigious awards including the MRC fellowship and the NIHR Clinician Scientist award in the UK and awards from the European Psychiatry Association and the European College of Neuropsychopharmacology.<\/p>\n<p>\u201cPOT\u201dential neural mechanisms underlying the effects of cannabis in man<\/p>\n<p>Cannabis is one of the most widely used illicit drugs worldwide and has a number of cognitive and symptomatic effects in man. Hence, acute pharmacological challenge with cannabis in man may be a useful, reversible and safe way to investigate their neural underpinnings. Here, I will summarize the results from a series of studies in healthy human volunteers that combine pharmacological challenge with cannabinoids and neuroimaging techniques to examine the neural mechanisms underlying the symptomatic effects of cannabinoids and how the effects may vary depending on the specific cannabinoid. I will also present data that suggest how the how genetic factors moderate sensitivity to the symptomatic effects of cannabis as well as its neural underpinnings.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Sagnik Bhattacharyya is a Senior Clinical Lecturer and Consultant Psychiatrist at the Institute of Psychiatry, Psychology &#038; Neuroscience at King\u2019s College London and the associated Maudsley hospital, UK. Following his initial medical and psychiatric training in India, he went to the UK, where he had further training in psychiatry at the Maudsley hospital and [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-454","wcc_ponente","type-wcc_ponente","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/worldcannabisconferences.com\/conferencias\/wp-json\/wp\/v2\/wcc_ponente\/454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/worldcannabisconferences.com\/conferencias\/wp-json\/wp\/v2\/wcc_ponente"}],"about":[{"href":"https:\/\/worldcannabisconferences.com\/conferencias\/wp-json\/wp\/v2\/types\/wcc_ponente"}],"version-history":[{"count":0,"href":"https:\/\/worldcannabisconferences.com\/conferencias\/wp-json\/wp\/v2\/wcc_ponente\/454\/revisions"}],"wp:attachment":[{"href":"https:\/\/worldcannabisconferences.com\/conferencias\/wp-json\/wp\/v2\/media?parent=454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}